- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Testosterone deficiency
- Meeting Date: March 2021
- Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 851KB)
- Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 47KB)
Testosterone – March 2021
Testosterone: Transdermal cream 50 mg per mL, 50 mL; AndroForte 5®
Last updated
2 July 2021